VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection by Kerr, D, Dunn, J, Langman, M, Smith, J, Midgley, R, Iveson, C, McConkey, C

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION by Midgley, R, McConkey, C, Langman, M, Smith, J, Julier, P, Iveson, C, Johnstone, E, Chen, X, Dunn, J, Kerr, D, Grp, V

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. by Kerr, D, Dunn, J, Langman, M, Smith, J, Midgley, R, Stanley, A, Stokes, J, Julier, P, Iveson, C, Duvvuri, R, McConkey, C

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. by Midgley, R, McConkey, C, Johnstone, E, Dunn, J, Smith, J, Grumett, SA, Julier, P, Iveson, C, Yanagisawa, Y, Warren, B, Langman, M, Kerr, D